Udi: (b)(4).Per the instructions for use (ifu), valve migration requiring intervention is a potential adverse event associated with transcatheter aortic valve replacement.According to literature review, valve migration results when forces acting on the transcatheter heart valve (thv) overcome the strength of attachment of the valve to the aortic wall.Stent valves are subjected to antegrade ejection forces during systole.Less-than-severe and non-uniformly distributed calcification of the native leaflets, incorrect bioprosthetic valve sizing, and incomplete frame expansion, can contribute to valve migration.Additionally, residual overhanging leaflets can exert downwards force during diastole, causing migration of the thv towards the left ventricle.The edwards thv patient screening manual advises the operator on pre-procedure assessment of the aortic valve and root, taking into consideration the degree and distribution of native leaflet calcification.The procedural didactic instructs the operator on proper positioning and deployment of the valve, including all procedural and anatomical considerations.Physicians are extensively trained by edwards before they are qualified to use the transcatheter heart valve (thv).Training includes patient screening, device preparation, approach, deployment, imaging, procedure-specific training manuals and proctored procedures.The correct sizing, alignment and positioning of the device are emphasized as key factors to the placement and fixation of the device.In this case, there was no allegation or indication a device malfunction contributed to this adverse event.The root cause of the event remains indeterminable but may have been impacted by patient and procedural related factors.The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
|
Edwards received notification from a field clinical specialist that at 1 year and 5 months, a patient with a 26 mm sapien 3, implanted in the aortic position (90/10 aortic/ventricular), underwent a valve in valve procedure due to migration.The patient was symptomatic for heart failure. aortography revealed aforementioned s3 had migrated (30/70 aortic/ventricular). a new sapien 3 ultra was prepared and deployed in good position.The patient was stable post procedure and sent to recovery.
|